Sarcopenia: From definition to treatment
| dc.creator | Dionyssiotis Y., Kapsokoulou A., Samlidi E., Angoules A.G., Papathanasiou J., Chronopoulos E., Kostoglou-Athanassiou I., Trovas G. | en |
| dc.date.accessioned | 2023-01-31T07:57:13Z | |
| dc.date.available | 2023-01-31T07:57:13Z | |
| dc.date.issued | 2017 | |
| dc.identifier | 10.14310/horm.2002.1764 | |
| dc.identifier.issn | 11093099 | |
| dc.identifier.uri | http://hdl.handle.net/11615/73376 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | Hormones | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042235343&doi=10.14310%2fhorm.2002.1764&partnerID=40&md5=bb781ac00b9c20ed0a431f72c107e265 | |
| dc.subject | ACE 031 protein | en |
| dc.subject | dipeptidyl carboxypeptidase inhibitor | en |
| dc.subject | enobosarm | en |
| dc.subject | ghrelin | en |
| dc.subject | ghrelin agonist | en |
| dc.subject | glucose | en |
| dc.subject | glucose transporter 4 | en |
| dc.subject | gsk 971086 | en |
| dc.subject | gtx-024 | en |
| dc.subject | hormone inhibitor | en |
| dc.subject | immunoglobulin G1 | en |
| dc.subject | lgd-4033 | en |
| dc.subject | myostatin | en |
| dc.subject | pindolol | en |
| dc.subject | recombinant protein | en |
| dc.subject | selective androgen receptor modulator | en |
| dc.subject | somatomedin C | en |
| dc.subject | tirasemtiv | en |
| dc.subject | unclassified drug | en |
| dc.subject | aerobic exercise | en |
| dc.subject | aging | en |
| dc.subject | allergic urticaria | en |
| dc.subject | arthralgia | en |
| dc.subject | aseptic meningitis | en |
| dc.subject | atrial fibrillation | en |
| dc.subject | carpal tunnel syndrome | en |
| dc.subject | clinical medicine | en |
| dc.subject | comorbidity | en |
| dc.subject | confusion | en |
| dc.subject | diarrhea | en |
| dc.subject | dual energy X ray absorptiometry | en |
| dc.subject | dyspnea | en |
| dc.subject | edema | en |
| dc.subject | exercise | en |
| dc.subject | fatigue | en |
| dc.subject | fragility fracture | en |
| dc.subject | glucose homeostasis | en |
| dc.subject | health care | en |
| dc.subject | human | en |
| dc.subject | hyperglycemia | en |
| dc.subject | muscle function | en |
| dc.subject | muscle mass | en |
| dc.subject | muscle strength | en |
| dc.subject | myalgia | en |
| dc.subject | Note | en |
| dc.subject | nutrition | en |
| dc.subject | physical activity | en |
| dc.subject | prevalence | en |
| dc.subject | protein synthesis | en |
| dc.subject | quality of life | en |
| dc.subject | sarcopenia | en |
| dc.subject | skeletal muscle | en |
| dc.subject | treatment indication | en |
| dc.subject | aging | en |
| dc.subject | diet | en |
| dc.subject | pathophysiology | en |
| dc.subject | sarcopenia | en |
| dc.subject | Aging | en |
| dc.subject | Diet | en |
| dc.subject | Exercise | en |
| dc.subject | Humans | en |
| dc.subject | Muscle Strength | en |
| dc.subject | Muscle, Skeletal | en |
| dc.subject | Sarcopenia | en |
| dc.subject | Hellenic Endocrine Society | en |
| dc.title | Sarcopenia: From definition to treatment | en |
| dc.type | other | en |
Αρχεία σε αυτό το τεκμήριο
| Αρχεία | Μέγεθος | Τύπος | Προβολή |
|---|---|---|---|
|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |
|||

